Cryoport Supports ImmunoCellular Therapeutics' 120-Site Phase III Clinical Trial With Cold Chain Logistics - Yahoo Finance

3252016 Cryoport Supports ImmunoCellular Therapeutics 120shySite Phase III Clinical Trial With Cold Chain Logistics shy Yahoo Finance

httpfinanceyahoocomnewscryoportshysupportsshyimmunocellularshytherapeuticsshy120shy130000050html 16

ˠ Cryoport IncMarch 3 2016 800 AM

Cryoport SupportsImmunoCellularTherapeutics 120shySitePhase III Clinical TrialWith Cold ChainLogistics

IRVINE Calif March 3 2016 PRNewswire shyshy Cryoport Inc(CYRX) (Company) the worlds leading cryogenic logisticscompany today announced that it will be supporting thecryogenic logistics requirements of ImmunoCellularTherapeutics (NYSE MKT IMUC) (ImmunoCellular)registrational Phase III glioblastoma clinical trial across 120 sitesin North America and Europe This clinical trial is designed toevaluate the safety and efficacy of ImmunoCellulars leadproduct candidate ICTshy107 a patientshyderived dendritic cellshybased immunotherapy

Anthony Gringeri ImmunoCellulars Senior Vice PresidentStrategic Resources commented We chose to partner withCryoport for the registrational trial of ICTshy107 because of theircold chain logistics expertise and proven ability to manage thechallenges of transporting valuable temperatureshysensitivecryogenically frozen materials Of additional significance is theirspecialized logistics operating platform for the timely and securedelivery of our immunotherapy to the large number of patientsparticipating in our trial in the US Canada and Europe

ImmunoCellulars ICTshy107 immunotherapy targets six differentantigens peptides that are tumor markers associated with theaggressive cancer of the brain glioblastoma More than 400patients with newly diagnosed glioblastoma will be enrolled

Recommended Games

More games raquo

Compare Brokers

Recent+058CYRX 173

More Pop Out

Quote Lookup Go

Finance HomeMy PortfolioMy Quotes NewsMarket DataYahoo OriginalsBusiness amp FinancePersonal FinanceCNBCContributors

CYRX 058

What to read next

How I beat six unjust NYC parking tickets

11 Rules For Building Wealth After 50Sponsored The Motley Fool

Trash the reporter Donald Trumprsquos fanslambaste Yahoo Finance

Activists like Ackman Icahn and Loebseem to be everywhere Herersquos wh hellip

Fri Mar 25 2016 531pm EDT shy US Markets are closed

Follow Yahoo Finance

Search Finance Search Web Sign In Mail

Home Mail Search News Sports Finance Celebrity Weather Answers Flickr MobileTry Yahoo Finance on Firefox raquoMore⋁



across 120 sites to participate in the trial The regimen in thePhase III trial is standard of care plus or minus ICTshy107immunotherapy The regimen includes induction immunotherapy(4 doses in month 1) and maintenance (monthly doses throughmonth 12 or progression)

Jerrell Shelton Chief Executive Officer of Cryoport Inccommented Our agreement with ImmunoCellular Therapeuticsmarks a substantial milestone in Cryoports history as it is one ofthe largest volume trials we have supported We are delightedthat our advanced cryogenic logistics solutions will play anintegral role in the execution of this Phase III trial We will ensurethe successful delivery of ImmunoCellulars immuneshybasedtherapy to the 120 sites located in North America and Europe aswe employ our technology based solutions With thispartnership Cryoport now supports 64 clinical trials worldwideten of which are Phase III trials

The biotech industry continues to develop advanced biologicand immunotherapeutic solutions that are sensitive to theirenvironment and require the maintaining of specifictemperatures during storage and transit As these therapieshave moved from the development stage and into the clinic theneed for a safe effective and consistent way to transport themhas become clearer to everyone in the industry We areconfident that our track record makes Cryoport an indispensableresource for the advancement of the biologics marketconcluded Mr Shelton

About Cryoport Inc

Cryoport is the premier provider of cryogenic logistics solutionsto the life sciences industry through its purposeshybuilt proprietarypackaging information technology and specialized cold chainlogistics expertise The Company provides leading edge logisticssolutions for biologic materials such as immunotherapies stemcells CARshyT cells and reproductive cells for clients worldwideCryoport actively supports pointsshyofshycare CROs centrallaboratories pharmaceutical companies contract manufacturersand university researchers For more information visitwwwcryoportcom

To download Cryoports investor relations app which offersaccess to SEC documents press releasesvideos audiocasts and more please click to download fromyour iPhone and iPad or Android mobile device

Forward Looking Statements

Statements in this news release which are not purely historicalincluding statements regarding Cryoport Incs intentionshopes beliefs expectations representations projections plansor predictions of the future are forwardshylooking statements withinthe meaning of the Private Securities Litigation Reform Act of1995 It is important to note that the companys actual resultscould differ materially from those in any such forwardshylooking

What Trump and Peeps have in commonplus other interesting facts about hellip

What The Baywatch Stars Look LikeNow shy IncredibleSponsored Your Daily Dish

Portfolio manager explains why he likesthese four stocks

These startups want to put an end tocrowded offices

Hot cars at the 2016 New York Auto Show



statements Factors that could cause actual results to differmaterially include but are not limited to risks and uncertaintiesassociated with the effect of changing economic conditionstrends in the products markets variations in the companys cashflow market acceptance risks and technical development risksThe companys business could be affected by a number of otherfactors including the risk factors listed from time to time in thecompanys SEC reports including but not limited to the annualreport on Form 10shyK for the year ended March 31 2015 Thecompany cautions investors not to place undue reliance on theforwardshylooking statements contained in this press releaseCryoport Inc disclaims any obligation and does not undertaketo update or revise any forwardshylooking statements in this pressrelease

Logo shyhttpphotosprnewswirecomprnh20140401NY95107LOGO

To view the original version on PR Newswirevisithttpwwwprnewswirecomnewsshyreleasescryoportshysupportsshyimmunocellularshytherapeuticsshy120shysiteshyphaseshyiiishyclinicalshytrialshywithshycoldshychainshylogisticsshy300230317html

Rates

Tighten And Lift Saggy Neck (DoThis Before Bed)Sponsored Beverly Hills MD

Arctic sea ice dips to record low NASA

Cruz Blames Trump for Tabloid Smear

Warren Buffett And Bill OrsquoNeil StockScreens IBD Investing Show

What These 00s Icons Look Like NowIs LudicrousSponsored Time To Break

The Federal Reserve is ignoringCongress



Share this

Recommended for You

View Comments (0)

httpfinanceyahoocomnewscryoportshysupportsshyimmunocellularshytherapeuticsshy120shy130000050htmlsoc_src=copy

9 hidden dividend stock gemspriced to buy nowThese nine hidden dividend gems offer investors amix of high yield and growth All are smallshy or midshycap stocks that are overlooked or misunderstoodThe Street

5 Dividend Secrets toBuild Wealth After 50I used to worry if Social Securitywould be enough for ahellipcomfortable retirement But that

The Trump Network WasScandalous The GovernmentrsquosResponse May Have Been WorseDonald Trumprsquos presidential campaign is rooted inthe idea that with him at the helm Americans will allThe Fiscal Times

Microsoft axes chatbot that learneda little too much onlineSAN FRANCISCO (AP) mdash OMG Did you hear aboutAssociated Press

Gilead v Merck Thatrsquos ItWhen Merck (MRK) claimed Gilead Sciences (GILD)had infringed on its patents in creating blockbusterBarrons

Scientist Reveals AHuge Lie About HeartHealthRecent research reveals that70 of heart attacks are causehellip

5 Random Reasons Your CreditScore Could Go UpThere are some behindshytheshyscenes changes that cancause your credit score to go up without you doingmuch of anything at allCreditcom

Linn Energy Exchange Offer May Avoid TaxHeadacheExchange offering from LinnCo gives options to investors shouldthey want to stay investedReal Money

Everyone is worried that a thirdChina bubble is about to popFirst Chinas property bubble popped Then ChinasBusiness Insider

Worst Exercise ForMen Over 40 (Avoid)Study finds that for men over 40certain exercise speeds aging hellipcauses weight gain Discover the

The Motley Fool Sponsored

MSFT $5421 044

GILD $9132 138

Heart Health Dangers shy Princeton Sponsored

CS $1436 shy245

Max Workouts Sponsored

Brussels Suicide Bomber Aided in ParisAttacks

Why some stores dont take chip creditcards

This Wedding Dance StunnedEveryone (VIDEO)Sponsored LittleBudha

Steph Curry is just one part of UnderArmours hotshystreak

Heres Why Being Mr right WorksEvery TimeSponsored Mr Right

Ford may join Uber and Lyft in the rideshysharing business



Trump Leads GOP Field in Bloomberg PoliticsPollMar 23 shyshy Mark Halperin and John Heilemann discuss a BloombergPolitics national poll and the Republican presidential candidatesrsquochances on ldquoWith All Due RespectrdquoBloomberg Video

Play

Blackstone Mutual Fund Loses HalfIts AssetsA Blackstone Group LP mutual fund that allocatesBloomberg

7 Habits of Highly Frugal PeoplePeople who pay off their debt and achieve financialindependence dont succeed by accident Theyestablish habits that allow them to consistently reachtheir goals over the long haulKiplingercom

Now Is Your MomentQualify for up to $2000

Obama Faces Painful Choice inSyria as Peace Talks FalterFollowing the ceasefire in Syria negotiated a monthago by Washington and Moscow Secretary of StateJohn Kerry must now work out a longshytermThe Fiscal Times

15 IRS Audit Red Flagsistockphoto Ever wonder why some tax returns areeyeballed by the Internal Revenue Service whilemost are ignored Short on personnel and fundingthe IRS audited only 086 of all individual returns inKiplingercom

The hottest debate in the stockmarket right now was actuallystarted by Donald Trump in 1999Donald Trump is a lot of things Right now hesknown mostly as the Republican presidentialBusiness Insider

How Older MenTighten Their SkinMen reduce the look of wrinklessagging skin and fine lines withhellipthis affordable and effective skin

Herersquos the Armyrsquos New HybridVehicle Half Tank Half JeepThe US Army just dropped nearly a quarter of aThe Fiscal Times

Batman v Superman off to apowerful start with a $277shymillionshowing on ThursdayThe $250shymillion movie Batman v Superman Dawnof Justice is off to a strong start as it begins itsLos Angeles Times

Padma Warrior on Being a FemaleEngineer in 1984March 24 shyshy This week on Studio 10 host EmilyChang sits down with NextEV US CEO PadmasreeWarrior to discuss going head to head with Tesla andBloomberg VideoPlay

Shark Tank Stars

SPHIX $802 shy062

Scottrade Sponsored

LifeCell Sponsored

OSK $4032 315

sharing business

Behind US GDP Data Is Reason forRecession Worry Weak Profits

Rolling Stones gear up for historic freeconcert in Cuba

1 Reason Not To Go Online If You LiveIn The USSponsored SaferWeb

Job totals trail preshyrecession levels in 10US states

Netflix admits downgrading video qualityon mobile WSJ



Brilliant MortgageAdvice

Merrill Lynch Sees Verizon DealMaking the Huge FrontierDividend Safer247wallstcom

Aldi opens in the Southland Whatyou need to knowAldi a German discount grocer opened its first eightstores in Southern California this week By the end ofthe year it plans to have 45 stores in the regionLos Angeles Times

3 Ways to Reduce Debt as You Near RetirementThe various types of debt shyshy from credit cards student loans or evena mortgage shyshy take on a different story in portfolios as people getolder The New York Federal Reserve found that 67shyyearshyolds sawUSNews amp World Report

4 Signs Youre At RiskFor A Heart Attack70 of Americans who haveexperienced a heart attack sayhellipthey had no idea it was coming

Rockefeller Family Fund hits Exxondivests from fossil fuelsHOUSTONNEW YORK (Reuters) shy The RockefellerReuters

Load more stories

The Easy Loan Site Sponsored

MERshyPM $2565 027

Princeton Nutrients Sponsored

XOM $8398 027

Copyright copy 2016 ltahref=httpusrdyahoocomfinancenewsprnewsSIG=10r1gbf7phttpwwwprnewswirecomgtPR

Newswireltagt All rights reserved Republication or redistribution ofPRNewswire content is expressly prohibited without the prior written

consent of PRNewswire PRNewswire shall not be liable for any errors ordelays in the content or for any actions taken in reliance thereon

Data Disclaimer

Help Suggestions Privacy About Our Ads Terms



across 120 sites to participate in the trial The regimen in thePhase III trial is standard of care plus or minus ICTshy107immunotherapy The regimen includes induction immunotherapy(4 doses in month 1) and maintenance (monthly doses throughmonth 12 or progression)

Jerrell Shelton Chief Executive Officer of Cryoport Inccommented Our agreement with ImmunoCellular Therapeuticsmarks a substantial milestone in Cryoports history as it is one ofthe largest volume trials we have supported We are delightedthat our advanced cryogenic logistics solutions will play anintegral role in the execution of this Phase III trial We will ensurethe successful delivery of ImmunoCellulars immuneshybasedtherapy to the 120 sites located in North America and Europe aswe employ our technology based solutions With thispartnership Cryoport now supports 64 clinical trials worldwideten of which are Phase III trials

The biotech industry continues to develop advanced biologicand immunotherapeutic solutions that are sensitive to theirenvironment and require the maintaining of specifictemperatures during storage and transit As these therapieshave moved from the development stage and into the clinic theneed for a safe effective and consistent way to transport themhas become clearer to everyone in the industry We areconfident that our track record makes Cryoport an indispensableresource for the advancement of the biologics marketconcluded Mr Shelton

About Cryoport Inc

Cryoport is the premier provider of cryogenic logistics solutionsto the life sciences industry through its purposeshybuilt proprietarypackaging information technology and specialized cold chainlogistics expertise The Company provides leading edge logisticssolutions for biologic materials such as immunotherapies stemcells CARshyT cells and reproductive cells for clients worldwideCryoport actively supports pointsshyofshycare CROs centrallaboratories pharmaceutical companies contract manufacturersand university researchers For more information visitwwwcryoportcom

To download Cryoports investor relations app which offersaccess to SEC documents press releasesvideos audiocasts and more please click to download fromyour iPhone and iPad or Android mobile device

Forward Looking Statements

Statements in this news release which are not purely historicalincluding statements regarding Cryoport Incs intentionshopes beliefs expectations representations projections plansor predictions of the future are forwardshylooking statements withinthe meaning of the Private Securities Litigation Reform Act of1995 It is important to note that the companys actual resultscould differ materially from those in any such forwardshylooking

What Trump and Peeps have in commonplus other interesting facts about hellip

What The Baywatch Stars Look LikeNow shy IncredibleSponsored Your Daily Dish

Portfolio manager explains why he likesthese four stocks

These startups want to put an end tocrowded offices

Hot cars at the 2016 New York Auto Show






Rates









Share this

Recommended for You

View Comments (0)













MSFT $5421 044

GILD $9132 138


CS $1436 shy245











Play











Shark Tank Stars

SPHIX $802 shy062

Scottrade Sponsored

LifeCell Sponsored

OSK $4032 315

sharing business














Load more stories


MERshyPM $2565 027


XOM $8398 027




Data Disclaimer







Rates









Share this

Recommended for You

View Comments (0)













MSFT $5421 044

GILD $9132 138


CS $1436 shy245











Play











Shark Tank Stars

SPHIX $802 shy062

Scottrade Sponsored

LifeCell Sponsored

OSK $4032 315

sharing business














Load more stories


MERshyPM $2565 027


XOM $8398 027




Data Disclaimer




Share this

Recommended for You

View Comments (0)













MSFT $5421 044

GILD $9132 138


CS $1436 shy245











Play











Shark Tank Stars

SPHIX $802 shy062

Scottrade Sponsored

LifeCell Sponsored

OSK $4032 315

sharing business














Load more stories


MERshyPM $2565 027


XOM $8398 027




Data Disclaimer





Play











Shark Tank Stars

SPHIX $802 shy062

Scottrade Sponsored

LifeCell Sponsored

OSK $4032 315

sharing business














Load more stories


MERshyPM $2565 027


XOM $8398 027




Data Disclaimer










Load more stories


MERshyPM $2565 027


XOM $8398 027




Data Disclaimer


Documents

Cryoport Supports ImmunoCellular Therapeutics' 120-Site Phase III Clinical Trial With Cold Chain Logistics - Yahoo Finance